Literature DB >> 12169221

Chronic progressive external ophthalmoplegia.

Andrew G Lee1, Paul W Brazis.   

Abstract

Chronic progressive external ophthalmoplegia (CPEO) is a descriptive term for a heterogenous group of disorders characterized by chronic, progressive, bilateral, and usually symmetric ocular motility deficit and ptosis. Significant pain, proptosis, or pupil involvement are not features of CPEO and should prompt evaluation for alternative etiologies. Mitochondrial DNA mutations are increasingly being recognized as the etiology for CPEO syndromes. Clinicians should recognize the specific syndromes associated with CPEO, characterized by variable systemic, neurologic, or other findings. Treatment is limited, but newer therapies are being investigated.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12169221     DOI： 10.1007/s11910-002-0067-5

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


  44 in total

1.  Characterization of a novel human putative mitochondrial transporter homologous to the yeast mitochondrial RNA splicing proteins 3 and 4.

Authors:  F Y Li; K Nikali; J Gregan; I Leibiger; B Leibiger; R Schweyen; C Larsson; A Suomalainen
Journal:  FEBS Lett       Date:  2001-04-06       Impact factor: 4.124

2.  Molecular epidemiologic study of mitochondrial DNA mutations in patients with mitochondrial diseases in Taiwan.

Authors:  C Y Pang; C C Huang; M Y Yen; E K Wang; K P Kao; S S Chen; Y H Wei
Journal:  J Formos Med Assoc       Date:  1999-05       Impact factor: 3.282

3.  Impaired activation of oxygen consumption and blood flow in visual cortex of patients with mitochondrial encephalomyopathy.

Authors:  M S Vafaee; E Meyer; A Gjedde
Journal:  Ann Neurol       Date:  2000-10       Impact factor: 10.422

4.  External Ophthalmoplegia, Pigmentary Degeneration of the Retina, and Cardiomyopathy: A Newly Recognized Syndrome.

Authors:  T P Kearns
Journal:  Trans Am Ophthalmol Soc       Date:  1965

5.  Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions.

Authors:  G Van Goethem; B Dermaut; A Löfgren; J J Martin; C Van Broeckhoven
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

6.  Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease.

Authors:  M A Tarnopolsky; G Parise
Journal:  Muscle Nerve       Date:  1999-09       Impact factor: 3.217

7.  Improved brain and muscle mitochondrial respiration with CoQ. An in vivo study by 31P-MR spectroscopy in patients with mitochondrial cytopathies.

Authors:  B Barbiroli; S Iotti; R Lodi
Journal:  Biofactors       Date:  1999       Impact factor: 6.113

8.  Common deletion of mitochondrial DNA in a 5-year-old girl with failure to thrive, ptosis, ophthalmoplegia and ragged-red fibers.

Authors:  V Seyrantepe; G Kale; H Topaloglu; A Alikasifoglu; M Ozgüc
Journal:  Brain Dev       Date:  1999-09       Impact factor: 1.961

9.  Ultrastructural analysis of extraocular muscle in chronic progressive external ophthalmoplegia.

Authors:  A Carta; T D'Adda; F Carrara; M Zeviani
Journal:  Arch Ophthalmol       Date:  2000-10

10.  Association in the same patient of autosomal dominant progressive external ophthalmoplegia with multiple mtDNA deletions and X-linked ichthyosis: clinical, biochemical, histological, submicroscopic and molecular genetic study.

Authors:  A Federico; M T Dotti; E Cardaioli; G Grieco; A Malandrini; L Manneschi; K Plewnia; A Rufa; A Renieri; M Bruttini; G F Perticoni
Journal:  J Submicrosc Cytol Pathol       Date:  1998-10
View more
  9 in total

1.  Humanin expression in skeletal muscles of patients with chronic progressive external ophthalmoplegia.

Authors:  Tesseki Kin; Kazuma Sugie; Makito Hirano; Yu-Ichi Goto; Ichizo Nishino; Satoshi Ueno
Journal:  J Hum Genet       Date:  2006-04-26       Impact factor: 3.172

Review 2.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

Review 3.  Approach to a patient with blepharoptosis.

Authors:  Samira Yadegari
Journal:  Neurol Sci       Date:  2016-06-21       Impact factor: 3.307

4.  [Chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome : interdisciplinary diagnosis and therapy].

Authors:  B Wabbels; N Ali; W S Kunz; P Roggenkämper; C Kornblum
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

5.  Electron microscopic findings in levator muscle biopsies of patients with isolated congenital or acquired ptosis.

Authors:  Bettina Wabbels; Josef A Schroeder; Beate Voll; Heiko Siegmund; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-24       Impact factor: 3.117

Review 6.  Progressive External Ophthalmoplegia.

Authors:  Collin McClelland; Georgios Manousakis; Michael S Lee
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

7.  Progressive External Ophthalmoplegia Diagnosed in the Glaucoma Clinic: The Importance of a Complete Clinical Examination.

Authors:  Dimitrios Karagiannis; Loukas Kontomichos; Vasileios Tzimis; Efstratios Parikakis; Georgios Batsos; Michael Karampelas
Journal:  Clin Optom (Auckl)       Date:  2021-12-24

8.  Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia.

Authors:  Alejandro Horga; Robert D S Pitceathly; Julian C Blake; Catherine E Woodward; Pedro Zapater; Carl Fratter; Ese E Mudanohwo; Gordon T Plant; Henry Houlden; Mary G Sweeney; Michael G Hanna; Mary M Reilly
Journal:  Brain       Date:  2014-10-03       Impact factor: 13.501

Review 9.  Ptosis in childhood: A clinical sign of several disorders: Case series reports and literature review.

Authors:  P Pavone; Sung Yoon Cho; A D Praticò; R Falsaperla; M Ruggieri; Dong-Kyu Jin
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.